Brief: Zhaoke Ophthalmology Partners With TSH Biopharm For Taiwan Market
Dec 8 (Reuters) - Zhaoke Ophthalmology Ltd 6622.HK: PARTNERS WITH TSH BIOPHARM FOR TAIWAN MARKET TSH BIOPHARM GRANTED EXCLUSIVE DISTRIBUTION RIGHTS IN TAIWAN FOR BRIMOCHOLTM PF Further company coverage: 6622.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhaoke Ophthalmology
See all newsBrief: Zhaoke Ophthalmology Says Its Facility In Guangzhou Obtains GMP Certification From Australia's TGA
China's Zhaoke Ophthalmology H1 revenue rises
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved By Macau Pharmaceutical Administration Bureau
Brief: Zhaoke Ophthalmology Enters Into Definitive Agreement For Acquisition Of Global Rights To NVK002
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved For Use At Boao Super Hospital